NEW YORK (GenomeWeb News) – Waters today reported that its revenues in the third quarter were up 2 percent year over year, driven by broad-based demand in the life science markets.

The company posted revenues of $500.6 million, up from $493.2 million in Q3 2014, and beating the average Wall Street estimate of $493.2 million. Foreign currency effects reduced sales growth by roughly 7 percent, Waters said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

Futurism writes that gene doping could be the next generation of cheating in sports.